* MD Becker Partners reporting live from the JP Morgan Healthcare Conference This week, nearly 6,500 registrants gathered in San Francisco, California for the JP Morgan Healthcare Conference to hear 25-minute presentations from 338 life science companies. For industry executives and investors, the annual event serves as a good barometer for the rest of...
Read More »
Posts Tagged ‘ AZN ’
Allos Therapeutics
ALTH
AMAG
AMAG Pharmaceuticals
American Society of Clinical Oncology
Amgen
AMGN
Amicus Therapeutics
AMLN
ASCO
BIIB
Biogen Idec
biotech
biotechnology
BMY
cancer
CELG
Celgene
CEPH
Cephalon
Cougar Biotechnology
CYCC
Cyclacel Pharmaceuticals
Dendreon
DNDN
Eli Lilly & Co
FOLD
genentech
GENZ
GlaxoSmithKline
GSK
HGSI
life sciences
LLY
OSIR
Osiris Therapeutics
PFE
Pfizer
prostate cancer
Provenge
roche
Seattle Genetics
SGEN
SNY
Soligenix
Biotech Deal Activity Declines…The Pause that Refreshes?
Three Recent Biotechnology Activist Wins by Carl Icahn
Although a controversial topic, activist hedge funds and private equity firms typically use a small equity stake in an underperforming company to put public pressure on its management and board of directors with the goal of increasing stakeholder value through cost cutting, changes in corporate strategy or management, capital restructuring, asset divestiture and other...
Read More »







